AKCEA-ANGPTL3-LRx
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AKCEA-ANGPTL3-LRx, covering 2021-02-16 to 2021-02-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) [Phase 2]